Why is Anuh Pharma falling/rising?

As of 18-Sep, Anuh Pharma Ltd's stock price is currently at 87.79, reflecting a decrease of 0.2, or 0.23%. The stock has been gaining for the last two days, rising 0.97% during this period, although it remains lower than its 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has underperformed significantly, with a return of -15.46% compared to the market's slight gain of 0.08%. The company's low debt-to-equity ratio and attractive valuation with a price-to-book value of 2.7 suggest some positive aspects; however, the recent decline in profits by 20.2% and negative quarterly results have contributed to a bearish sentiment around the stock.
In the broader market context, Anuh Pharma's short-term performance of +0.69% over the past week is notably lower than the Sensex's gain of +1.80% during the same period. This underperformance highlights the stock's struggle to attract investor interest, as evidenced by a significant drop in delivery volume, which fell by nearly 50% against the five-day average. Despite being liquid enough for trading, the overall negative sentiment surrounding the company's long-term growth prospects and recent financial results has led to a cautious outlook among investors, contributing to the stock's current decline.